Leidos (NYSE: LDOS) director awarded new shares and stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Leidos Holdings director Gary Stephen May reported equity grants as compensation. He received 1,067 shares of common stock at no cost, bringing his direct holdings to 11,204 shares. He was also awarded options on 1,281 shares at an exercise price of $131.26 per share.
The stock options vest and become exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholder meeting, and expire in 2033. These are routine director compensation awards rather than open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
May Gary Stephen
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,281 | $0.00 | -- |
| Grant/Award | Common Stock | 1,067 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,281 shares (Direct, null);
Common Stock — 11,204 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Common stock grant: 1,067 shares
Shares held after grant: 11,204 shares
Option grant size: 1,281 options
+3 more
6 metrics
Common stock grant
1,067 shares
Director equity award on 2026-05-08
Shares held after grant
11,204 shares
Director’s direct holdings following award
Option grant size
1,281 options
Right to buy Leidos common stock
Option exercise price
$131.26 per share
Stock option strike price
Option vesting trigger
Earlier of 1 year or next meeting
Vesting condition from footnote
Option expiration
2033-05-07
Scheduled option expiry date
Key Terms
stock option, exercise price, vest and become exercisable, annual meeting of the stockholders, +1 more
5 terms
stock option financial
"Stock Option (Right to Buy) with an exercise price of $131.2600"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "131.2600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest and become exercisable financial
"The option shall vest and become exercisable in full on the earlier of"
annual meeting of the stockholders regulatory
"the date that the next annual meeting of the stockholders of the Company is concluded"
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
What did Leidos (LDOS) director Gary Stephen May report in this Form 4?
Gary Stephen May reported receiving equity compensation from Leidos. He was granted 1,067 shares of common stock and stock options for 1,281 shares, reflecting routine director awards rather than open-market buying or selling activity in Leidos stock.
What are the key terms of the Leidos (LDOS) stock options granted to Gary Stephen May?
Gary Stephen May received stock options on 1,281 Leidos shares with a $131.26 exercise price. The options vest on the earlier of one year after grant or the next annual stockholder meeting’s conclusion, and they are scheduled to expire in 2033 if not exercised.
Is the Leidos (LDOS) Form 4 for Gary Stephen May a sign of insider buying or selling?
The Form 4 reflects compensation grants, not insider trading. Shares and options were awarded at no cost under a director compensation arrangement, so the filing does not show open-market buying or selling decisions by Gary Stephen May in Leidos stock.
When will Gary Stephen May’s Leidos (LDOS) stock options become exercisable?
The options become exercisable in full on the earlier of two dates: the first anniversary of the grant date or when Leidos’ next annual stockholder meeting concludes. This vesting condition is disclosed directly in the Form 4 footnote language.